Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial

From Aaushi
Jump to navigation Jump to search

Introduction

Study characteristics:

  • 8,500 patients ages 60-80 in China[1]

Treatment

Results:

More general terms

Additional terms

References

  1. 1.0 1.1 Phend C Lower BP Targets Again Affirmed in Major Trial. STEP trial from China shows major benefits in older population. MedPage Today August 30, 2021 https://www.medpagetoday.com/meetingcoverage/esc/94277
    Zhang W, Zhang S, Deng Y et al Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension. N Engl J Med. August 30, 2021 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34491661 https://www.nejm.org/doi/full/10.1056/NEJMoa2111437
  2. 2.0 2.1 Yang R, Huang R, Zhang L et al. Influence of baseline diastolic blood pressure on the effects of intensive blood pressure lowering: Results from the STEP randomized trial. Hypertension 2023 Oct 10; [e-pub] PMID: https://www.ncbi.nlm.nih.gov/pubmed/37814892 https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.123.21892